151 related articles for article (PubMed ID: 2534021)
1. [Reactivity and immunogenicity of Engerix B, the recombinant DNA vaccine against hepatitis B].
Borcić B; Gasparović V; Mihaljevic I; Aleraj B; Margan IG
Acta Med Iugosl; 1989; 43(4):247-54. PubMed ID: 2534021
[TBL] [Abstract][Full Text] [Related]
2. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
Gunn TR; Bosley A; Woodfield DG
N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
[TBL] [Abstract][Full Text] [Related]
3. Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure.
Rajapurkar MM; Gang S; Dabhi M; Kulkarni PS
J Nephrol; 2007; 20(5):596-601. PubMed ID: 17918146
[TBL] [Abstract][Full Text] [Related]
4. Suboptimal response to hepatitis B vaccine in drug users.
Rumi M; Colombo M; Romeo R; Boschini A; Zanetti A; Gringeri A; Mannucci PM
Arch Intern Med; 1991 Mar; 151(3):574-8. PubMed ID: 1848057
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and safety of recombinant yeast-derived hepatitis B vaccine in haemodialysis patients.
Fujiyama S; Yoshida K; Sato T; Shimada H; Deguchi T
Hepatogastroenterology; 1990 Dec; 37 Suppl 2():140-4. PubMed ID: 2150664
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of a recombinant yeast-derived hepatitis B vaccine (Engerix B) in children.
Moyes C; Milne A
N Z Med J; 1988 Apr; 101(843):162-4. PubMed ID: 2965799
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and reactogenicity of two recombinant hepatitis B vaccines in small infants: a randomized, double-blind comparative study.
Sapru A; Kulkarni PS; Bhave S; Bavdekar A; Naik SS; Pandit AN
J Trop Pediatr; 2007 Oct; 53(5):303-7. PubMed ID: 17478542
[TBL] [Abstract][Full Text] [Related]
8. Antibody response to hepatitis B immunization in infants born to HIV-infected mothers.
Thaithumyanon P; Punnahitananda S; Praisuwanna P; Thisyakorn U; Ruxrungtham K
J Med Assoc Thai; 2002 Mar; 85(3):277-82. PubMed ID: 12117014
[TBL] [Abstract][Full Text] [Related]
9. Safety and immunogenicity of a new mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in adults.
Raz R; Koren R; Bass D
Isr Med Assoc J; 2001 May; 3(5):328-32. PubMed ID: 11411195
[TBL] [Abstract][Full Text] [Related]
10. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I
Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
[TBL] [Abstract][Full Text] [Related]
11. A randomized double-blind clinical trial of a mammalian cell-derived recombinant DNA hepatitis B vaccine compared with a plasma-derived vaccine.
Halliday ML; Rankin JG; Bristow NJ; Coates RA; Corey PN; Strickler AC
Arch Intern Med; 1990 Jun; 150(6):1195-200. PubMed ID: 2141247
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of a new, low-cost recombinant hepatitis B vaccine derived from Hansenula polymorpha in adults.
Kulkarni PS; Raut SK; Patki PS; Phadke MA; Jadhav SS; Kapre SV; Dhorje SP; Godse SR
Vaccine; 2006 Apr; 24(17):3457-60. PubMed ID: 16530299
[TBL] [Abstract][Full Text] [Related]
13. [Reactivity and immunogenicity of Havrix 360 vaccine for hepatitis A].
Borcić B; Kovac S; Mihaljević I; Dobrovsak-Sourek V; Ljubicić M
Lijec Vjesn; 1996; 118(7-8):162-4. PubMed ID: 8965633
[TBL] [Abstract][Full Text] [Related]
14. The evaluation of Engerix-B in healthy Malaysian medical students.
Isahak I; Abdul Malik Y; Hakim AS; Baharin R
Singapore Med J; 1990 Aug; 31(4):314-6. PubMed ID: 2147781
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of immunogenicity and safety of Engerix B and Twinrix vaccine].
Gałaj A; Grześk G; Borys D; Durmowicz A; Grześk E; Szadujkis-Szadurski L
Wiad Lek; 2004; 57(5-6):217-20. PubMed ID: 15518064
[TBL] [Abstract][Full Text] [Related]
16. [Serologic response to a DNA recombinant vaccine against hepatitis B in natives of the Peruvian Amazonian jungle].
Colichón A; Vildósola H; Sjogren M; Cantella R; Rojas C
Rev Gastroenterol Peru; 1990; 10(2):71-4. PubMed ID: 2151848
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children.
Duval B; Gîlca V; Boulianne N; Deceuninck G; Rochette L; De Serres G
Vaccine; 2005 Jul; 23(31):4082-7. PubMed ID: 15963363
[TBL] [Abstract][Full Text] [Related]
18. Study of hepatitis B (HB) vaccine non-responsiveness among health care workers from an endemic area (Taiwan).
Yen YH; Chen CH; Wang JH; Lee CM; Changchien CS; Lu SN
Liver Int; 2005 Dec; 25(6):1162-8. PubMed ID: 16343067
[TBL] [Abstract][Full Text] [Related]
19. Immunologic evaluation of hepatitis B vaccine application in hospital staff.
Platkov E; Shlyakhov E; Glick Y; Khalemsky S; Fischbein A
Int J Occup Med Environ Health; 2003; 16(3):249-53. PubMed ID: 14587538
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of two different vaccination schemes against Hepatitis A and B in Mexican children and adolescents].
González-Huezo MS; Sánchez-Avila F; García Mayol M; Castro Narro G; Sixtos S; Lisker-Melman M; Kershenobich D
Rev Gastroenterol Mex; 2003; 68(4):271-6. PubMed ID: 15125329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
